{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T14:50:38Z","timestamp":1778251838026,"version":"3.51.4"},"reference-count":41,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2020,10,8]],"date-time":"2020-10-08T00:00:00Z","timestamp":1602115200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"},{"start":{"date-parts":[[2020,10,8]],"date-time":"2020-10-08T00:00:00Z","timestamp":1602115200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["J Clin Pharm Ther"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1111\/jcpt.13281","type":"journal-article","created":{"date-parts":[[2020,10,8]],"date-time":"2020-10-08T19:11:30Z","timestamp":1602184290000},"page":"310-318","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Hepatotoxicity with epidermal growth factor receptor tyrosine kinase inhibitors in non\u2013small\u2010cell lung cancer patients: A network meta\u2010analysis"],"prefix":"10.1155","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2784-6076","authenticated-orcid":false,"given":"Ziyang","family":"Wu","sequence":"first","affiliation":[{"name":"Department of Pharmacy Administration and Clinical Pharmacy School of Pharmaceutical Sciences Peking University Beijing China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suhua","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Administration and Clinical Pharmacy School of Pharmaceutical Sciences Peking University Beijing China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Du","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Administration and Clinical Pharmacy School of Pharmaceutical Sciences Peking University Beijing China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yibo","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Administration and Clinical Pharmacy School of Pharmaceutical Sciences Peking University Beijing China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaohui","family":"Xie","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Administration and Clinical Pharmacy School of Pharmaceutical Sciences Peking University Beijing China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2020,10,8]]},"reference":[{"key":"e_1_2_8_2_1","first-page":"1","article-title":"Global Epidemiology of Lung Cancer. Annals of","volume":"85","author":"Barta JA","year":"2019","journal-title":"Global Health"},{"key":"e_1_2_8_3_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1703413"},{"key":"e_1_2_8_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.lungcan.2017.11.005"},{"key":"e_1_2_8_5_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0810699"},{"key":"e_1_2_8_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(11)70184-X"},{"key":"e_1_2_8_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(13)70355-3"},{"key":"e_1_2_8_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(12)70087-6"},{"key":"e_1_2_8_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(17)30608-3"},{"key":"e_1_2_8_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(16)30508-3"},{"issue":"2","key":"e_1_2_8_11_1","first-page":"189","article-title":"Drug\u2010Drug Interactions, Safety, and Pharmacokinetics of EGFR Tyrosine Kinase Inhibitors for the Treatment of Non\u2010Small Cell Lung Cancer","volume":"9","author":"Kucharczuk CR","year":"2018","journal-title":"J Adv Pract Oncol"},{"key":"e_1_2_8_12_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2011.40.9433"},{"key":"e_1_2_8_13_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0909530"},{"issue":"2","key":"e_1_2_8_14_1","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/S1470-2045(09)70364-X","article-title":"Gefitinib versus cisplatin plus docetaxel in patients with non\u2010small\u2010cell lung cancer harbouring mutations of the epidermal growth factor receptor (WJTOG3405): an open label, randomised phase 3 trial","volume":"11","author":"Mitsudomi T","year":"2010","journal-title":"Lancet Oncol"},{"issue":"3","key":"e_1_2_8_15_1","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S1470-2045(11)70393-X","article-title":"Erlotinib versus standard chemotherapy as first\u2010line treatment for European patients with advanced EGFR mutation\u2010positive non\u2010small\u2010cell lung cancer (EURTAC): a multicentre, open\u2010label, randomised phase 3 trial","volume":"13","author":"Rafael R","year":"2012","journal-title":"Lancet Oncol"},{"key":"e_1_2_8_16_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2012.44.2806"},{"key":"e_1_2_8_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(13)70604-1"},{"key":"e_1_2_8_18_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdx359"},{"key":"e_1_2_8_19_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1612674"},{"key":"e_1_2_8_20_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1713137"},{"key":"e_1_2_8_21_1","unstructured":"HigginsJPT GreenS.Cochrane Handbook for Systematic Reviews of Interventions Version 5. 1. 0.http:\/\/www.cochrane\u2010handbook.org. Accessed 15 August 2019."},{"key":"e_1_2_8_22_1","doi-asserted-by":"publisher","DOI":"10.1002\/sim.1186"},{"key":"e_1_2_8_23_1","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2008.22"},{"key":"e_1_2_8_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2010.03.016"},{"issue":"15","key":"e_1_2_8_25_1","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1016\/j.ejca.2011.06.045","article-title":"A double\u2010blind, randomised, placebo\u2010controlled phase III intergroup study of gefitinib in patients with advanced NSCLC, non\u2010progressing after first line platinum\u2010based chemotherapy (EORTC 08021\/ILCP 01\/03)","volume":"47","author":"Gaafar RM","year":"2011","journal-title":"Eur J Cancer"},{"issue":"5","key":"e_1_2_8_26_1","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/S1470-2045(12)70117-1","article-title":"Gefitinib versus placebo as maintenance therapy in patients with locally advanced or metastatic non\u2010small\u2010cell lung cancer (INFORM; C\u2010TONG 0804): a multicentre, double\u2010blind randomised phase 3 trial","volume":"13","author":"Zhang L","year":"2012","journal-title":"Lancet Oncol"},{"key":"e_1_2_8_27_1","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2016.456"},{"key":"e_1_2_8_28_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2015.63.4154"},{"key":"e_1_2_8_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(16)30033-X"},{"key":"e_1_2_8_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(14)70452-8"},{"key":"e_1_2_8_31_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2015.61.8918"},{"key":"e_1_2_8_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(10)70112-1"},{"key":"e_1_2_8_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(15)00006-6"},{"key":"e_1_2_8_34_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.18.4408"},{"issue":"17","key":"e_1_2_8_35_1","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1200\/JCO.2009.26.5496","article-title":"Successful treatment with erlotinib after gefitinib\u2010related severe hepatotoxicity","volume":"28","author":"Takeda M","year":"2010","journal-title":"J Clin Oncol"},{"issue":"19","key":"e_1_2_8_36_1","doi-asserted-by":"crossref","first-page":"3213","DOI":"10.1200\/JCO.2006.05.7109","article-title":"Promising new treatment schedule for gefitinib responders after severe hepatotoxicity with daily administration","volume":"24","author":"Seki N","year":"2006","journal-title":"J Clin Oncol"},{"key":"e_1_2_8_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.lungcan.2015.08.004"},{"key":"e_1_2_8_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cllc.2014.12.004"},{"key":"e_1_2_8_39_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40264-013-0048-4"},{"issue":"7","key":"e_1_2_8_40_1","first-page":"1307","article-title":"Safety analysis of eight patients treated with erlotinib after severe gefitinib\u2010induced liver injury","volume":"37","author":"Ohashi Y","year":"2010","journal-title":"Gan To Kagaku Ryoho"},{"key":"e_1_2_8_41_1","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.8638-16"},{"key":"e_1_2_8_42_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.l5460"}],"container-title":["Journal of Clinical Pharmacy and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jcpt.13281","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/jcpt.13281","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jcpt.13281","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T18:05:43Z","timestamp":1671818743000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/jcpt.13281"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,8]]},"references-count":41,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["10.1111\/jcpt.13281"],"URL":"https:\/\/doi.org\/10.1111\/jcpt.13281","archive":["Portico"],"relation":{},"ISSN":["0269-4727","1365-2710"],"issn-type":[{"value":"0269-4727","type":"print"},{"value":"1365-2710","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,8]]},"assertion":[{"value":"2020-02-21","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-09-07","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-10-08","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}